BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 34712235)

  • 21. Leishmania donovani serine protease encapsulated in liposome elicits protective immunity in experimental visceral leishmaniasis.
    Das P; Paik D; Naskar K; Chakraborti T
    Microbes Infect; 2018 Jan; 20(1):37-47. PubMed ID: 28970116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Translating Observations From Leishmanization Into Non-Living Vaccines: The Potential of Dendritic Cell-Based Vaccination Strategies Against
    Seyed N; Peters NC; Rafati S
    Front Immunol; 2018; 9():1227. PubMed ID: 29922288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intranasal vaccine from whole Leishmania donovani antigens provides protection and induces specific immune response against visceral leishmaniasis.
    Helou DG; Mauras A; Fasquelle F; Lanza JS; Loiseau PM; Betbeder D; Cojean S
    PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009627. PubMed ID: 34403413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccination using live attenuated Leishmania donovani centrin deleted parasites induces protection in dogs against Leishmania infantum.
    Fiuza JA; Gannavaram S; Santiago Hda C; Selvapandiyan A; Souza DM; Passos LS; de Mendonça LZ; Lemos-Giunchetti Dda S; Ricci ND; Bartholomeu DC; Giunchetti RC; Bueno LL; Correa-Oliveira R; Nakhasi HL; Fujiwara RT
    Vaccine; 2015 Jan; 33(2):280-8. PubMed ID: 25475955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vector transmission of leishmania abrogates vaccine-induced protective immunity.
    Peters NC; Kimblin N; Secundino N; Kamhawi S; Lawyer P; Sacks DL
    PLoS Pathog; 2009 Jun; 5(6):e1000484. PubMed ID: 19543375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Paradox of a Phagosomal Lifestyle: How Innate Host Cell-
    Carneiro MB; Peters NC
    Front Immunol; 2021; 12():728848. PubMed ID: 34557194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-21 Deficiency Promotes the Early Th1 Immune Response and Resistance toward Visceral Leishmaniasis.
    Varikuti S; Verma C; Holcomb E; Jha BK; Viana A; Maryala R; Lamenza F; McElwain BK; Doni NY; Papenfuss T; Oghumu S; Gannavaram S; Nakhasi HL; Satoskar AR
    J Immunol; 2021 Sep; 207(5):1322-1332. PubMed ID: 34341171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of immunogenicity by live attenuated Leishmania donovani centrin deleted parasites in dogs.
    Fiuza JA; Santiago Hda C; Selvapandiyan A; Gannavaram S; Ricci ND; Bueno LL; Bartholomeu DC; Correa-Oliveira R; Nakhasi HL; Fujiwara RT
    Vaccine; 2013 Apr; 31(14):1785-92. PubMed ID: 23398933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on the protective efficacy of freeze thawed promastigote antigen of Leishmania donovani along with various adjuvants against visceral leishmaniasis infection in mice.
    Thakur A; Kaur H; Kaur S
    Immunobiology; 2015 Sep; 220(9):1031-8. PubMed ID: 26001730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA vaccine against visceral leishmaniasis: a promising approach for prevention and control.
    Kumar A; Samant M
    Parasite Immunol; 2016 May; 38(5):273-81. PubMed ID: 27009772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Innate immune defense in visceral leishmaniasis: cytokine mediated protective role by allogeneic effector cell.
    Manna PP; Chakrabarti G; Bandyopadhyay S
    Vaccine; 2010 Jan; 28(3):803-10. PubMed ID: 19879234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leishmania donovani: impairment of the cellular immune response against recombinant ornithine decarboxylase protein as a possible evasion strategy of Leishmania in visceral leishmaniasis.
    Yadav A; Amit A; Chaudhary R; Chandel AS; Mahantesh V; Suman SS; Singh SK; Dikhit MR; Ali V; Rabidas V; Pandey K; Kumar A; Das P; Bimal S
    Int J Parasitol; 2015 Jan; 45(1):33-42. PubMed ID: 25449949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leishmania major p27 gene knockout as a novel live attenuated vaccine candidate: Protective immunity and efficacy evaluation against cutaneous and visceral leishmaniasis in BALB/c mice.
    Elikaee S; Mohebali M; Rezaei S; Eslami H; Khamesipour A; Keshavarz H; Eshraghian MR
    Vaccine; 2019 May; 37(24):3221-3228. PubMed ID: 31047672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Live attenuated Leishmania donovani p27 gene knockout parasites are nonpathogenic and elicit long-term protective immunity in BALB/c mice.
    Dey R; Dagur PK; Selvapandiyan A; McCoy JP; Salotra P; Duncan R; Nakhasi HL
    J Immunol; 2013 Mar; 190(5):2138-49. PubMed ID: 23338240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutrophil-dendritic cell interaction plays an important role in live attenuated Leishmania vaccine induced immunity.
    Bhattacharya P; Ismail N; Saxena A; Gannavaram S; Dey R; Oljuskin T; Akue A; Takeda K; Yu J; Karmakar S; Dagur PK; McCoy JP; Nakhasi HL
    PLoS Negl Trop Dis; 2022 Feb; 16(2):e0010224. PubMed ID: 35192633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ubiquitin conjugation of open reading frame F DNA vaccine leads to enhanced cell-mediated immune response and induces protection against both antimony-susceptible and -resistant strains of Leishmania donovani.
    Sharma A; Madhubala R
    J Immunol; 2009 Dec; 183(12):7719-31. PubMed ID: 19933862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of cross-protection by genetically modified live-attenuated Leishmania donovani parasites against Leishmania mexicana.
    Dey R; Natarajan G; Bhattacharya P; Cummings H; Dagur PK; Terrazas C; Selvapandiyan A; McCoy JP; Duncan R; Satoskar AR; Nakhasi HL
    J Immunol; 2014 Oct; 193(7):3513-27. PubMed ID: 25156362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunity to visceral leishmaniasis: implications for immunotherapy.
    Khadem F; Uzonna JE
    Future Microbiol; 2014; 9(7):901-15. PubMed ID: 25156379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mast cells at the host-pathogen interface: host-protection versus immune evasion in leishmaniasis.
    Saha B; Tonkal AM; Croft S; Roy S
    Clin Exp Immunol; 2004 Jul; 137(1):19-23. PubMed ID: 15196239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 115 kDa serine protease confers sustained protection to visceral leishmaniasis caused by Leishmania donovani via IFN-γ induced down-regulation of TNF-α mediated MMP-9 activity.
    Choudhury R; Das P; De T; Chakraborti T
    Immunobiology; 2013 Jan; 218(1):114-26. PubMed ID: 22440312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.